Foam Sclerotherapy: A New Era

Archives of Dermatology

Volumn 139, Issue 11, 2003, Pages 1494-1496

  Hsu, Te Shao ^a   Weiss, Robert A ^b  

^a SkinCare Physicians of Chestnut Hill   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CARBON DIOXIDE; POLIDOCANOL; SCLEROSING AGENT; TETRADECYL SULFATE SODIUM;

AIR; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BRADYCARDIA; CLINICAL TRIAL; CONFUSION; COUGHING; DEEP VEIN THROMBOSIS; EDITORIAL; FOAM; FOAM SCLEROTHERAPY; HEART ARRHYTHMIA; HUMAN; INFLAMMATION; LUNG EMBOLISM; NECROSIS; NERVE PARALYSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION; PIGMENTATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESPIRATION DEPRESSION; RISK ASSESSMENT; SCINTIGRAPHY; SCLEROTHERAPY; SCOTOMA; SEIZURE; SURGICAL TECHNIQUE; SYRINGE; SYSTOLIC BLOOD PRESSURE; TELANGIECTASIA; THORAX DISEASE; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME; VEIN DIAMETER; VEIN DISEASE; VEIN INSUFFICIENCY; VERTIGO;

AIR; HISTORY, 20TH CENTURY; HUMANS; MICROSPHERES; SCLEROSING SOLUTIONS; SCLEROTHERAPY;

EID: 0242492101     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.139.11.1494     Document Type: Editorial

References (15)

1. Goldman MP, Sadick NS, Weiss RA. The history of dermatology in American phlebology. Dermatol Surg. 2000;26:616-621.
2. Cabrera J, Cabrera J Jr, Garcia-Olmedo MA, Redondo P. Treatment of venous malformations with sclerosant in microfoam form. Arch Dermatol. 2003;139:1409-1416.
3. Cabrera Garrido JR, Cabrera Garcia-Olmedo JR, Garcia-Olmedo Dominguez MA. Elargissement des limites de la schloerotherapie: noveaux produits. Sclerosants Phlebologie. 1997;50:181-188.
4. Orbach EJ. Sclerotherapy of varicose veins: utilization of intravenous air block. Am J Surg. 1944;66:362-366
5. Monfreux A. Traitement sclerosant des troncs saphenies et leurs collaterales de gros calibre par la methode. MUS Phlebologie. 1997;50:351-353.
6. Frullini A, Cavezzi A. Sclerosing foam in the treatment of varicose veins and telangiectases: history and analysis of safety and complications. Dermatol Surg. 2002;28:11-15.
7. Tessari L, Cavezzi A, Frullini A. Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatol Surg. 2001;27:58-60.
8. Belcaro G, Cesarone MR, Di Renzo A, et al. Foam-sclerotherapy, surgery, sclero-therapy, and combined treatment for varicose veins: a 10-year, prospective, randomized, controlled, trial (VEDICO trial). Angiology. 2003;54:307-315.
9. Frullini A. Review of the use of foams. Abstract presented at: UIP World Congress Chapter Meeting; August 27-31, 2003; San Diego, Calif.
10. Morrison N, Rogers C, Neuhardt D, Melfy K. Large-volume, ultrasound-guided polidocanol foam sclerotherapy: a prospective study of toxicity and complications. Abstract presented at: UIP World Congress Chapter Meeting; August 27-31, 2003; San Diego, Calif.
11. Bergan JJ, Weiss RA, Goldman MP. Extensive tissue necrosis following high-concentration sclerotherapy for varicose veins. Dermatol Surg. 2000;26:535-542.
12. Yamaki T, Nozaki M, Fujiwara O, Yoshida E. Duplex-guided foam sclerotherapy for the treatment of the symptomatic venous malformations of the face. Dermatol Surg. 2002;28:619-622.
13. Jacob AG, Driscoll DJ, Shaughnessy WJ, Stanson AW, Clay RP, Gloviczki P. Klippel-Trenaunay syndrome: spectrum and management. Mayo Clin Proc. 1998;73:28-36.
14. Mason KP, Neufeld EJ, Karian VE, Zurakowski D, Koka BV, Burrows PE. Coagulation abnormalities in pediatric and adult patients after sclerotherapy or embolization of vascular anomalies. AJR Am J Roentgenol. 2001;177:1359-1363.
15. Cabrera J, Becerra A, Cobo M, Garrido C, Cabrera M Jr. Ultrasound-guided injection of polidocanol microfoam in the management of venous leg ulcers. Abstract presented at: UIP World Congress Chapter Meeting; August 27-31,2003: San Diego, Calif.